Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 29;16(2):1503-1520.
doi: 10.21037/jtd-23-1626. Epub 2024 Feb 23.

Postoperative atrial fibrillation (POAF) after cardiac surgery: clinical practice review

Affiliations
Review

Postoperative atrial fibrillation (POAF) after cardiac surgery: clinical practice review

Orlando R Suero et al. J Thorac Dis. .

Abstract

Postoperative atrial fibrillation (POAF) after cardiac surgery is associated with elevated morbidity and mortality. Although current prediction models have limited efficacy, several perioperative interventions can reduce patients' risk of POAF. These begin with preoperative medications, including beta-blockers and amiodarone. Moreover, patients should be screened for preexisting atrial fibrillation (AF) so that concomitant surgical ablation and left atrial appendage occlusion can be performed in appropriate candidates. Intraoperative interventions such as posterior pericardiectomy can reduce mediastinal fluid accumulation, which is a trigger for POAF. Furthermore, many preventive strategies for POAF are implemented in the immediate postoperative period. Initiating beta-blockers, amiodarone, or both is reasonable for most patients. Overdrive atrial pacing, colchicine, and steroids have been used by some, although the evidence base is less robust. For patients with POAF, rate-control and rhythm-control strategies have comparable outcomes. Decision-making regarding anticoagulation should recognize that the stroke risk associated with POAF appears to be lower than that for general nonvalvular AF. The evidence that oral anticoagulation reduces stroke risk is less clear for POAF patients than for patients with general nonvalvular AF. Given that POAF tends to be shorter-lived and is associated with greater bleeding risks in the perioperative period, decisions regarding anticoagulation should be individualized. Finally, wearable technology and machine learning algorithms for better predicting and managing POAF appear to be coming soon. These technologies and a comprehensive clinical program could meaningfully reduce the incidence of this common complication.

Keywords: Postoperative atrial fibrillation (POAF); cardiac arrhythmia prevention; cardiac surgery; rate control; rhythm control.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-23-1626/coif). L.R.B. has received honoraria for lectures from Abiomed. M.W.S. has received speaker fees from Merck. M.R.M. is a consultant/advisory board member for Medtronic and Edwards Lifesciences. S.C. has served on advisory boards for Edwards Lifesciences, La Jolla Pharmaceutical Company, Eagle Pharmaceuticals, and Baxter Pharmaceuticals. S.C. serves as an unpaid editorial board member of Journal of Thoracic Disease. The other authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Summary of preoperative, intraoperative, and postoperative phases of care along with future technologies for preventing and treating postoperative atrial fibrillation after cardiac surgery.

References

    1. Caldonazo T, Kirov H, Rahouma M, et al. Atrial fibrillation after cardiac surgery: A systematic review and meta-analysis. J Thorac Cardiovasc Surg 2023;165:94-103.e24. 10.1016/j.jtcvs.2021.03.077 - DOI - PubMed
    1. Wang MK, Meyre PB, Heo R, et al. Short-term and Long-term Risk of Stroke in Patients With Perioperative Atrial Fibrillation After Cardiac Surgery: Systematic Review and Meta-analysis. CJC Open 2022;4:85-96. 10.1016/j.cjco.2021.09.011 - DOI - PMC - PubMed
    1. Matos JD, McIlvaine S, Grau-Sepulveda M, et al. Anticoagulation and amiodarone for new atrial fibrillation after coronary artery bypass grafting: Prescription patterns and 30-day outcomes in the United States and Canada. J Thorac Cardiovasc Surg 2021;162:616-624.e3. 10.1016/j.jtcvs.2020.01.077 - DOI - PMC - PubMed
    1. Akintoye E, Sellke F, Marchioli R, et al. Factors associated with postoperative atrial fibrillation and other adverse events after cardiac surgery. J Thorac Cardiovasc Surg 2018;155:242-251.e10. 10.1016/j.jtcvs.2017.07.063 - DOI - PubMed
    1. Conen D, Wang MK, Devereaux PJ, et al. New-Onset Perioperative Atrial Fibrillation After Coronary Artery Bypass Grafting and Long-Term Risk of Adverse Events: An Analysis From the CORONARY Trial. J Am Heart Assoc 2021;10:e020426. 10.1161/JAHA.120.020426 - DOI - PMC - PubMed